Aim
To evaluate the effects of the metallic reservoir and the use of gas within the Aeroform™ tissue expander with respect to the radiation dose distribution.
Images for this section: Fig. 1 : An illustration of the AirXpander™ system.
Methods and materials
Dosimetric effects of using a metallic reservoir within a breast tissue expander during external beam radiotherapy were investigated. To view the internal components of the reservoir, it was removed from the tissue expander and imaged on a Varian AS500 electronic portal imager. To calculate the relative density of each component within the reservoir, an ionization chamber within solid water was used to measure the dose and compared to a simulation within the Pinnacle treatment planning system (TPS). To examine the relative dose profile along the length of the reservoir, the reservoir was exposed on EBT3 film and analysed using SNC Patient™. In-vivo Dosimetry was performed using a RANDO® Woman phantom. Thermo-luminescent dosimeters were placed within the wax bolus enveloping the tissue expander.
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Fig. 2:
The metallic reservoir and the signal receiver removed from within the AirXpander breast tissue expander system. 
Results
Imaging the reservoir on the electronic portal imager revealed it consists of 3 distinct components. The densities assigned in the TPS, which resulted in calculated doses which matched the measured doses were; Section 1 = 0 g/cm 3 , Section 2 = 2.8 g/cm 3 and Section 3 = 0.7 g/cm 3 . Relative dose reductions were observed due to the metallic case;
Section 1 = 20%, Section 2 = 40% and Section 3 = 30%. Entrance doses ranged from 2.39 -2.53 Gy for both the medial and lateral beams. Exit doses ranging from 1.10 -1.71 Gy were observed in both beams. There was a significant difference in measured and calculated doses at exit locations in the beam.
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Conclusion
Dosimetric effects due to the metallic reservoir within the Aeroform breast tissue expander have been demonstrated and have been observed to be significant. To increase the dosimetric accuracy when contouring, individual components of the reservoir should be distinguished. Our in-vivo dosimetry experiment with the RANDO® demonstrated that dose homogeneity may be difficult to achieve in the surrounding tissue.
In addition it may be difficult to verify the planned dose due to the scattering effects of the reservoir. The Aeroform™ is a novel expander that may be increasingly utilised due to its inherent simplicity and ease of use. As such we welcome its introduction but recommend stringent patient dose monitoring when utilised in patients undergoing radiotherapy.
The authors would like to specially acknowledge AirXpanders for their generous donation of the Aeroform™ unit for this study.
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